| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.GENE.2003.09.042 |
| P698 | PubMed publication ID | 14697505 |
| P50 | author | Rogier Versteeg | Q55459165 |
| P2093 | author name string | Max M van Noesel | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1-15 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Gene | Q5531065 |
| P1476 | title | Pediatric neuroblastomas: genetic and epigenetic 'danse macabre' | |
| P478 | volume | 325 |
| Q40113078 | 1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma. |
| Q39681366 | A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients |
| Q39959474 | ATAD 3A and ATAD 3B are distal 1p-located genes differentially expressed in human glioma cell lines and present in vitro anti-oncogenic and chemoresistant properties |
| Q38521214 | Altered expression of cell cycle genes distinguishes aggressive neuroblastoma |
| Q36276501 | Artificial neural network classifier predicts neuroblastoma patients' outcome |
| Q40299236 | Bcl-2 is a key regulator for the retinoic acid-induced apoptotic cell death in neuroblastoma |
| Q40166261 | CSK controls retinoic acid receptor (RAR) signaling: a RAR-c-SRC signaling axis is required for neuritogenic differentiation |
| Q34708427 | Changes in gene expression profiling of apoptotic genes in neuroblastoma cell lines upon retinoic acid treatment |
| Q36200232 | Chemotherapy curable malignancies and cancer stem cells: a biological review and hypothesis |
| Q81767654 | Childhood solid tumours: a developmental disorder |
| Q59796509 | Co-expression of IL-15 enhances anti-neuroblastoma effectivity of a tyrosine hydroxylase-directed DNA vaccination in mice |
| Q50267850 | Copy number defects of G1-cell cycle genes in neuroblastoma are frequent and correlate with high expression of E2F target genes and a poor prognosis |
| Q47255619 | Correlation between NM23 protein overexpression and prognostic value and clinicopathologic features of ovarian cancer: a meta-analysis |
| Q58321451 | Cyclin D1 is a direct transcriptional target of GATA3 in neuroblastoma tumor cells |
| Q36380887 | DNA hypomethylation affects cancer-related biological functions and genes relevant in neuroblastoma pathogenesis |
| Q38328604 | DeltaNp73 antisense activates PUMA and induces apoptosis in neuroblastoma cells |
| Q38906557 | Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma. |
| Q26999187 | Epigenetic deregulation of microRNAs in rhabdomyosarcoma and neuroblastoma and translational perspectives |
| Q36099024 | Epstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model |
| Q41976538 | Expression of URG4/URGCP, Cyclin D1, Bcl-2, and Bax genes in retinoic acid treated SH-SY5Y human neuroblastoma cells |
| Q47648708 | Extracellular NME proteins: a player or a bystander? |
| Q33424045 | Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma |
| Q40854205 | Frizzled2 signaling regulates growth of high-risk neuroblastomas by interfering with β-catenin-dependent and β-catenin-independent signaling pathways |
| Q34901718 | Functional modulation of the metastatic suppressor Nm23-H1 by oncogenic viruses |
| Q36919289 | Genistein inhibits estradiol- and environmental endocrine disruptor-induced growth effects on neuroblastoma cells in vitro |
| Q34334471 | Identification of BIRC6 as a novel intervention target for neuroblastoma therapy |
| Q81320661 | Identification of NM23-H2 as a tumour-associated antigen in chronic myeloid leukaemia |
| Q45111014 | Immunohistochemical analysis of PDK1, PHD3 and HIF-1α expression defines the hypoxic status of neuroblastoma tumors |
| Q37225885 | Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells |
| Q36446146 | Inhibitors of cathepsins B and L induce autophagy and cell death in neuroblastoma cells |
| Q38677396 | MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63. |
| Q39579597 | Microgravity assay of neuroblastoma: in vitro aggregation kinetics and organoid morphology correlate with MYCN expression |
| Q35069781 | Mitochondrial ferritin, a new target for inhibiting neuronal tumor cell proliferation |
| Q38010376 | Molecular and genetic bases of neuroblastoma |
| Q38088418 | New prognostic markers in neuroblastoma. |
| Q34210060 | Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma |
| Q38903938 | Oncolytic adenovirus-mediated short hairpin RNA targeting MYCN gene induces apoptosis by upregulating RKIP in neuroblastoma |
| Q35064095 | Pharmacologic management of high-risk neuroblastoma in children |
| Q37257631 | Phosphatidylinositol 3-kinase regulation of gastrin-releasing peptide-induced cell cycle progression in neuroblastoma cells |
| Q34363570 | Population-based survival estimates for childhood cancer in Australia during the period 1997–2006 |
| Q40088634 | Proapoptotic compound ARC targets Akt and N-myc in neuroblastoma cells. |
| Q46527475 | Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification |
| Q36038476 | Role of gastrointestinal hormones in neuroblastoma |
| Q37995020 | Role of stemness-related molecules in neuroblastoma |
| Q39608525 | Sensitization to TRAIL-induced apoptosis in human neuroblastoma SK-N-AS cells by NF-κB inhibitors is dependent on reactive oxygen species (ROS). |
| Q34994130 | Silencing of CDC42 inhibits neuroblastoma cell proliferation and transformation |
| Q35005945 | Silencing of doublecortin-like (DCL) results in decreased mitochondrial activity and delayed neuroblastoma tumor growth |
| Q35568697 | Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma |
| Q34281881 | Targeting Aurora kinase-A downregulates cell proliferation and angiogenesis in neuroblastoma |
| Q91895786 | Targeting anaplastic lymphoma kinase in neuroblastoma |
| Q41287020 | The Many Faces of MDM2 Binding Partners |
| Q40335896 | The combination of sulfinosine and 8-Cl-cAMP induces synergistic cell growth inhibition of the human neuroblastoma cell line in vitro. |
| Q37836006 | The connections between neural crest development and neuroblastoma |
| Q33756262 | The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma. |
| Q28477838 | The proteasome inhibitor bortezomib enhances ATRA-induced differentiation of neuroblastoma cells via the JNK mitogen-activated protein kinase pathway |
| Q92711863 | Vps28 Is Involved in the Intracellular Trafficking of Awd, the Drosophila Homolog of NME1/2 |
Search more.